Balance Sheet

Current Liabilities	224.2m
Accounts Payable	46.2m
Accrued Liabilities	7.8m
Short-Term Debt	164.5m
Other Current Liabilities	5.6m
Non-Current Liabilities	48.2m
Other Non-Current Liabilities	48.2m

Currency: CNY

	Dec-2013	Dec-2014	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	3	0	64	144	225	258	469	104
Cash	3	0	64	144	225	258	469	104
Short-Term Investments	0	0	0	0	0	0	0	0
Total Receivables	14	15	40	49	81	162	64	98
Accounts Receivables	1	2	28	36	71	141	51	79
Other Receivables	13	13	12	12	10	21	13	19
Inventory	10	11	20	46	68	112	97	104
Other Current Assets	1	1	4	1	4	273	40	16
Total Current Assets	28	27	128	239	379	806	669	322
PP&E Net	15	15	136	252	370	777	967	996
PP&E Gross	0	0	136	252	370	777	967	996
Accumulated Depreciation	0	0	16	40	53	77	113	170
Intangible Assets	1	15	16	31	30	49	49	48
Long-Term Investments	1	1	0	0	0	0	3 185	3 445
Other Long-Term Assets	0	0	0	2	2	3	0	0
Total Assets	45 N/A	57 +27%	280 +388%	524 +87%	781 +49%	1 634 +109%	4 870 +198%	4 810 -1%
Liabilities
Accounts Payable	1	2	24	42	38	106	82	46
Accrued Liabilities	0	0	6	6	4	7	9	8
Short-Term Debt	5	10	61	119	200	437	102	165
Other Current Liabilities	12	18	7	3	16	15	14	6
Total Current Liabilities	18	29	99	169	259	565	208	224
Long-Term Debt	0	0	0	0	0	0	0	0
Deferred Income Tax	0	0	0	5	11	23	41	44
Other Liabilities	1	1	1	1	1	1	1	5
Total Liabilities	19 N/A	31 +61%	100 +226%	176 +75%	271 +55%	589 +117%	249 -58%	272 +9%
Equity
Common Stock	20	20	49	101	101	101	202	202
Retained Earnings	0	0	92	175	337	872	901	818
Additional Paid In Capital	6	6	39	72	72	72	3 518	3 518
Total Equity	26 N/A	27 +2%	180 +575%	348 +94%	510 +46%	1 045 +105%	4 621 +342%	4 538 -2%
Total Liabilities & Equity	45 N/A	57 +27%	280 +388%	524 +87%	781 +49%	1 634 +109%	4 870 +198%	4 810 -1%
Shares Outstanding
Common Shares Outstanding	30	30	202	202	202	202	202	202

Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206